Application 022008
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 2MG BASE | Yes | Yes |
| 002 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 4MG BASE | Yes | No |
| 004 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 8MG BASE | Yes | No |
| 005 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 12MG BASE | Yes | No |
| 006 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 6MG BASE | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022008-001 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | |
| N022008-002 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | |
| N022008-003 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | |
| N022008-004 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | |
| N022008-005 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-10-31 | |
| N022008-006 | REQUIP XL | ROPINIROLE HYDROCHLORIDE | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-04-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N022008-001 | REQUIP XL | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022008-002 | REQUIP XL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022008-003 | REQUIP XL | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022008-004 | REQUIP XL | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022008-005 | REQUIP XL | EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-10-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022008-006 | REQUIP XL | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-04-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022008-001 | REQUIP XL | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022008-002 | REQUIP XL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022008-003 | REQUIP XL | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022008-004 | REQUIP XL | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022008-005 | REQUIP XL | EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-10-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022008-006 | REQUIP XL | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-04-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022008-001 | REQUIP XL | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022008-002 | REQUIP XL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022008-003 | REQUIP XL | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022008-004 | REQUIP XL | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022008-005 | REQUIP XL | EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-10-31 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022008-006 | REQUIP XL | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-04-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022008-001 | REQUIP XL | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022008-002 | REQUIP XL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022008-003 | REQUIP XL | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022008-004 | REQUIP XL | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022008-005 | REQUIP XL | EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-10-31 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022008-006 | REQUIP XL | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-04-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022008-001 | REQUIP XL | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022008-002 | REQUIP XL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022008-003 | REQUIP XL | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022008-004 | REQUIP XL | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022008-005 | REQUIP XL | EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-10-31 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022008-006 | REQUIP XL | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-04-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022008-001 | REQUIP XL | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022008-002 | REQUIP XL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022008-003 | REQUIP XL | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022008-004 | REQUIP XL | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022008-005 | REQUIP XL | EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-10-31 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022008-006 | REQUIP XL | EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2009-04-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022008-001 | REQUIP XL | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022008-002 | REQUIP XL | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022008-003 | REQUIP XL | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022008-004 | REQUIP XL | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2008-06-13 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N022008-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-005 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-006 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-005 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-006 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N022008-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022008-005 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022008-006 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-005 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-006 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-005 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-006 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-004 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-005 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-006 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-004 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-005 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-006 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-005 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-006 | AB | 1 | ea99ee380514… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N022008-001 | 8303986 | 2021-04-12 | Drug product | 2012-11-26 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-001 | 7927624 | 2021-12-02 | U-20 | Drug product | 2011-05-17 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-002 | 8303986 | 2021-04-12 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022008-002 | 7927624 | 2021-12-02 | U-20 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-003 | 8303986 | 2021-04-12 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022008-003 | 7927624 | 2021-12-02 | U-20 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-004 | 8303986 | 2021-04-12 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022008-004 | 7927624 | 2021-12-02 | U-20 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-005 | 8303986 | 2021-04-12 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022008-005 | 7927624 | 2021-12-02 | U-20 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-006 | 8303986 | 2021-04-12 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022008-006 | 7927624 | 2021-12-02 | U-20 | Drug product | 74a2ff9319b5… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022008-001 | 8303986 | 2021-04-12 | Drug product | 2012-11-26 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022008-001 | 7927624 | 2021-12-02 | U-20 | Drug product | 2011-05-17 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N022008-002 | 8303986 | 2021-04-12 | Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022008-002 | 7927624 | 2021-12-02 | U-20 | Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022008-003 | 8303986 | 2021-04-12 | Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022008-003 | 7927624 | 2021-12-02 | U-20 | Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022008-004 | 8303986 | 2021-04-12 | Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022008-004 | 7927624 | 2021-12-02 | U-20 | Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022008-005 | 8303986 | 2021-04-12 | Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022008-005 | 7927624 | 2021-12-02 | U-20 | Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022008-006 | 8303986 | 2021-04-12 | Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022008-006 | 7927624 | 2021-12-02 | U-20 | Drug product | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-001 | 8303986 | 2021-04-12 | Drug product | 2012-11-26 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-001 | 7927624 | 2021-12-02 | U-20 | Drug product | 2011-05-17 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-002 | 8303986 | 2021-04-12 | Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-002 | 7927624 | 2021-12-02 | U-20 | Drug product | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-003 | 8303986 | 2021-04-12 | Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-003 | 7927624 | 2021-12-02 | U-20 | Drug product | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-004 | 8303986 | 2021-04-12 | Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-004 | 7927624 | 2021-12-02 | U-20 | Drug product | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-005 | 8303986 | 2021-04-12 | Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-005 | 7927624 | 2021-12-02 | U-20 | Drug product | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-006 | 8303986 | 2021-04-12 | Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022008-006 | 7927624 | 2021-12-02 | U-20 | Drug product | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022008-001 | 8303986 | 2021-04-12 | Drug product | 2012-11-26 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022008-001 | 7927624 | 2021-12-02 | U-20 | Drug product | 2011-05-17 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N022008-002 | 8303986 | 2021-04-12 | Drug product | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022008-002 | 7927624 | 2021-12-02 | U-20 | Drug product | 5aa47cf7b7d7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N022008-001 | M-203 | 2020-03-23 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-002 | M-203 | 2020-03-23 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-003 | M-203 | 2020-03-23 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-004 | M-203 | 2020-03-23 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-005 | M-203 | 2020-03-23 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022008-006 | M-203 | 2020-03-23 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-001 | M-203 | 2020-03-23 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-002 | M-203 | 2020-03-23 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-003 | M-203 | 2020-03-23 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-004 | M-203 | 2020-03-23 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-005 | M-203 | 2020-03-23 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N022008-006 | M-203 | 2020-03-23 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-001 | M-203 | 2020-03-23 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-002 | M-203 | 2020-03-23 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-003 | M-203 | 2020-03-23 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-004 | M-203 | 2020-03-23 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-005 | M-203 | 2020-03-23 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N022008-006 | M-203 | 2020-03-23 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-001 | M-203 | 2020-03-23 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-002 | M-203 | 2020-03-23 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-003 | M-203 | 2020-03-23 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-004 | M-203 | 2020-03-23 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-005 | M-203 | 2020-03-23 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022008-006 | M-203 | 2020-03-23 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-001 | M-203 | 2020-03-23 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-002 | M-203 | 2020-03-23 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-003 | M-203 | 2020-03-23 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-004 | M-203 | 2020-03-23 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-005 | M-203 | 2020-03-23 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022008-006 | M-203 | 2020-03-23 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-001 | M-203 | 2020-03-23 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-002 | M-203 | 2020-03-23 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-003 | M-203 | 2020-03-23 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-004 | M-203 | 2020-03-23 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-005 | M-203 | 2020-03-23 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022008-006 | M-203 | 2020-03-23 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | A-S Medication Solutions | a97d5e2d-4a17-4d80-9216-1b0780199502 | 2026-03-23 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | Northwind Health Company, LLC | ab6d21b6-2584-4b97-e053-2a95a90adc50 | 2026-01-01 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | SOLCO HEALTHCARE US, LLC | 7734ef0b-584f-42dd-a8b5-adbdf4e4df93 | 2025-05-30 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | SOLCO HEALTHCARE US, LLC | 5823b3a2-3256-4d94-97b4-ec6b940312f4 | 2025-05-28 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | Bryant Ranch Prepack | 3b8bb729-e084-4d45-9774-63cae192be32 | 2025-01-29 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | AvKARE | abd344d9-7635-62a2-d4e1-38fc46937397 | 2025-01-09 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | AvPAK | e699a31a-25fc-554b-e053-2a95a90a843a | 2025-01-09 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | American Health Packaging | 6849b3c0-e36b-4bea-82f2-b33ae3d44c95 | 2025-01-08 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 48a63d7e-c0af-4b09-863c-2af7beb2e80f | 2024-10-24 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ROPINIROLE HYDROCHLORIDE | ROPINIROLE HYDROCHLORIDE | Bryant Ranch Prepack | 00c0ab77-914a-4e8a-bcb7-24cecacfebb1 | 2024-10-07 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | Bryant Ranch Prepack | 6c10444a-48da-469d-bf8f-1e6e0b7e15f8 | 2023-10-30 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | Proficient Rx LP | 89e3865c-1fe1-4f29-9606-8830df4bbe53 | 2023-08-01 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
| ropinirole hydrochloride | ROPINIROLE HYDROCHLORIDE | A-S Medication Solutions | 9c4dacc6-cebc-4f42-85fc-41083512b290 | 2023-03-01 | Warnings, Adverse reactions | ROPINIROLE HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0007-4882 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4882 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4883 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4883 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4885 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4887 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4887 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4888 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
| 0007-4888 | REQUIP | ropinirole hydrochloride | GlaxoSmithKline LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 68104 | SUPPL | 2021-07-16 |
| 68103 | SUPPL | 2021-07-16 |
| 68077 | SUPPL | 2021-07-14 |
| 68076 | SUPPL | 2021-07-14 |
| 47699 | SUPPL | 2017-03-24 |
| 47663 | SUPPL | 2017-03-24 |
| 38074 | SUPPL | 2014-09-03 |
| 38073 | SUPPL | 2014-09-03 |
| 16757 | SUPPL | 2014-09-03 |
| 16756 | SUPPL | 2014-09-03 |
| 29063 | SUPPL | 2014-09-02 |
| 29062 | SUPPL | 2014-09-02 |
| 6673 | SUPPL | 2014-09-02 |
| 6672 | SUPPL | 2014-09-02 |
| 29061 | SUPPL | 2009-04-16 |
| 16755 | SUPPL | 2009-04-16 |
| 21903 | ORIG | 2008-12-29 |
| 16754 | SUPPL | 2008-11-07 |
| 6671 | SUPPL | 2008-11-03 |
| 16753 | ORIG | 2008-07-09 |
| 29060 | ORIG | 2008-07-08 |
| 29059 | ORIG | 2008-06-20 |